| Date Filed | Type | Description |
| 05/02/2023 |
4
| Gros David-Alexandre C (CEO) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 383,299 options to buy
@ $2.3, valued at
$881.6k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Gros David-Alexandre C (CEO) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 108,000 options to buy
@ $3.97, valued at
$428.8k
|
|
| 12/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2020 |
4
| Gros David-Alexandre C (CEO) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 18,278 options to buy
@ $500, valued at
$9.1M
|
|
| 09/15/2020 |
3
| Gros David-Alexandre C (CEO) has filed a Form 3 on Novus Therapeutics, Inc. |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/09/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 12/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |